Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Remdesivir, Molnupiravir and Nirmatrelvir remain active a... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
0
Authors
Laura Vangeel
9 more
Laura Vangeel
•
Winston Chiu
7 more
•
Dirk Jochmans
Published
January 24, 2022
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Antiviral Research
Topics
Biology
Biochemistry
Chemistry
Medicine
Pathology
Show all topics
DOI
10.1016/j.antiviral.2022.105252
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Antiviral Research
Topics
Biology
Biochemistry
Chemistry
Medicine
Pathology
Show all topics
DOI
10.1016/j.antiviral.2022.105252
License
CC-BY
Other Formats
PDF
